Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Tafsure Tenofovir Alafenamide Tablets 25 mg
Tafsure is formulated with Tenofovir Alafenamide, a more advanced version of tenofovir that provides effective antiviral action with improved safety and tolerability. This medication is used primarily for the management of chronic Hepatitis B and offers significant benefits in reducing viral replication and protecting liver function.
Uses of Tafsure Tenofovir Alafenamide Tablets 25 mg
Chronic Hepatitis B Management: Used for the treatment of chronic Hepatitis B virus infection in adults and pediatric patients aged 12 years and older.
Viral Load Reduction: Helps in reducing the HBV viral load, which is crucial in managing the progression of the disease and preventing complications.
Liver Health Support: Assists in preserving liver function and reducing liver inflammation and fibrosis associated with chronic HBV infection.
Benefits of Tafsure Tenofovir Alafenamide Tablets 25 mg
Effective Antiviral Action: Tenofovir Alafenamide is known for its strong antiviral efficacy in reducing HBV viral replication and controlling the disease.
Improved Safety Profile: Compared to older formulations, Tenofovir Alafenamide has a lower risk of affecting kidney function and bone mineral density, enhancing overall safety.
Convenient Dosage: With a lower dose of 25 mg, Tafsure provides effective viral suppression with fewer side effects.
Enhanced Tolerability: The improved formulation offers better tolerability, making it easier for patients to adhere to long-term treatment.
Supports Long-Term Liver Health: By managing HBV effectively, it helps in reducing the risk of liver damage and other related complications.
Mechanism of Action of Tafsure Tenofovir Alafenamide Tablets 25 mg
Tenofovir Alafenamide: Tenofovir Alafenamide is a prodrug that is converted into its active form, Tenofovir, within the cells. Tenofovir inhibits the reverse transcriptase enzyme, which is essential for HBV replication. By blocking this enzyme, Tenofovir reduces the ability of the virus to replicate and spread, thereby controlling the infection.